Hologic, Inc. (NASDAQ:HOLX) reported upbeat earnings for its third quarter, but issued soft guidance on Monday.
Hologic reported quarterly earnings of $1.06 per share which beat the analyst consensus estimate of $1.02 per share. The company reported quarterly sales of $1.011 billion which beat the analyst consensus estimate of $1.000 billion, according to data from Benzinga Pro.
“In our third quarter of fiscal 2024, Hologic returns to top-line reported growth and once again exceeded the high-end of our guidance for both the top and bottom-line,” said Stephen P. MacMillan, the Company’s Chairman, President and Chief Executive Officer. “Our strong fiscal quarter and year-to-date results …